Gallentes, Lyca L.
HRN: 19-25-64 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/07/2024
CEFUROXIME 1.5GM (VIAL)
11/07/2024
11/13/2024
IV
1.5g
Q8
D&C
Waiting Final Action